Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMARTEST: dapagliflozin versus metformin in early type 2 diabetes
2024-516228-33-00Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing dapagliflozin arm with metformin arm (2 arms). Primary endpoint: Time to first composite event. Started Aug 2024; status: completed.
02
Drugs
dapagliflozinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2024-516228-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516228-33-00.